Marker Therapeutics, Inc.
General ticker "MRKR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $25.6M (TTM average)
Marker Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -10.4%.
Estimated limits based on current volatility of 6.0%: low 0.89$, high 1.01$
Factors to consider:
- Total employees count: 5 (0.0%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Going concern doubt, Clinical trial failure, Regulatory and compliance, Supply chain disruptions, Insufficient capital
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.91$, 2.56$]
- 2026-12-31 to 2027-12-31 estimated range: [0.94$, 2.59$]
Financial Metrics affecting the MRKR estimates:
- Positive: with PPE of -1.6 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: negative Net income
- Negative: negative Operating cash flow
- Positive: -0.07 < Investing cash flow per share per price, % of 0
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term MRKR quotes
Long-term MRKR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3.31MM | $6.59MM | $0.00MM |
| Operating Expenses | $17.89MM | $17.71MM | $12.89MM |
| Operating Income | $-14.58MM | $-11.12MM | $-12.89MM |
| Non-Operating Income | $0.54MM | $0.44MM | $0.71MM |
| R&D Expense | $10.42MM | $13.47MM | $11.80MM |
| Income(Loss) | $-14.04MM | $-10.68MM | $-12.18MM |
| Taxes | $0.00MM | $0.05MM | $-0.02MM |
| Other Income(Loss) | $5.81MM | $0.00MM | $0.00MM |
| Net Income(Loss)* | $-8.24MM | $-10.73MM | $-12.16MM |
| Stockholders Equity | $14.05MM | $18.56MM | $16.80MM |
| Assets | $17.13MM | $22.02MM | $19.07MM |
| Operating Cash Flow | $-16.44MM | $-10.91MM | $-12.01MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $18.66MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $1.11MM | $14.99MM | $9.86MM |
| Earnings Per Share** | $-0.94 | $-1.20 | $-0.79 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.